ArticleJournal for immunotherapy of cancer2020

Avelumab as second-line therapy for metastatic, platinum-treated urothelial carcinoma in the phase Ib JAVELIN Solid Tumor study: 2-year updated efficacy and safety analysis.

Andrea B Apolo et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.